10, in October, 65438 was selected as one of the "Top Enterprises with Most Potential in China 100", ranking 57th.
In July, Guan Hao Bio successfully landed on Shenzhen Growth Enterprise Market;
......
20 10 year
10, 65438 was selected as "Top Enterprises with the Most Potential in China 100", ranking 91;
In August, he was awarded the title of "2008-2009 tax credit A taxpayer";
10 was selected as "20 10 Deloitte's Top 50 High-tech and High-growth China".
In February, 65438 was selected as "Deloitte 20 10 Asia-Pacific Top 500 with High Technology and High Growth".
In 2009
June 5438+10, approved by the National Development and Reform Commission to build "National High-tech Industrialization Demonstration Project of Regenerated Biofilm";
In February, Hong Kong Guan Hao was established;
In June, the foundation stone of Guan Hao Bio-industrial Park was laid;
In July, "biological wound protection film" was registered by SFDA;
Awarded "Zero2IPO-the most valuable enterprise in China in 2009";
1 1 was selected as "Top 50 Deloitte High-tech and High-growth China in 2009", ranking 20th;
65438+February was selected as "2009 Deloitte Asia-Pacific Top 500 High-tech Growth", ranking 49th;
Won the title of "Key Overseas Chinese Entrepreneurship Team" of Overseas Chinese Affairs Office.
the year of 2008
/kloc-in June, 2008, it was awarded the "Top 30 Enterprises with the Most Investment Value in China in 2008" by China International Investment Private Equity Forum;
The company has passed ISO 13485: 2003 and ISO900 1:2000: 2000 quality system certification;
Shanghai Marketing Center was established in April;
In May, the share reform was completed and "Guangdong Guanhao Biotechnology Co., Ltd." was established;
In June, it was awarded by the National Development and Reform Commission to build the "National Engineering Laboratory for Regenerative Medical Implants";
In September, at the 5th China International Finance Forum and 2008 Lujiazui Finance Expo, it was awarded the title of "Top 10 Most Innovative Enterprises with Investment Value in China".
65438+ 10, which was named "Top 50 High-tech and High-growth China in 2008 (ranked 1 1) and Top 500 Asia-Pacific (ranked 28th) by Deloitte.
Having passed the accreditation of high-tech enterprises organized by the Ministry of Science and Technology;
165438+ 10 officially launched the new English name Grand Hope Biotechnology Co, ltd. ..
In 2007
From June+10, 5438, Guangdong Province undertook the Tenth Five-Year Scientific and Technological Key Project "Research on Animal Tissue Biomaterials in Tissue Engineering" and passed the national appraisal with excellent results;
The company undertook the 863 project "Development of Small Diameter Bio-artificial Blood Vessel with High Anticoagulant Induced Regeneration";
In February, 65438 was named as the top company with the most investment value 100 in Asia in 2007 by the American Wall Street investment magazine Red Herring.
"Chest Surgery Repair Membrane" was registered by SFDA.
In 2006
Moved to Guangzhou Science City in May;
In June, the first product "Meningeal Architecture" was registered by SFDA in China.
In 2003
Successfully reorganized the strategic structure in March and entered a rapid development channel;
In May this year, it won the funding of government science and technology projects for the first time.
1999
10 company was established in Guangzhou.